Besides CD133 expression, NSCLC cells expressing CD44, NANOG, OCT4, SOX2, and ALDHA1 were shown to be resistant to cisplatin through NOTCH3-mediated activation of autophagy (88). This evidence concerns the gene NOTCH3 and non-small cell lung carcinoma.